Q2 2024 Holdings
Filed 2024-08-14 | 70 holdings | $423.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Merus N V | COM | N5749R100 | $36.9M | 623,628 | 8.7% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $35.3M | 465,710 | 8.3% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $21.1M | 517,734 | 5.0% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $18.5M | 1,102,000 | 4.4% |
| Erasca Inc(ERAS) | COM | 29479A108 | $18.4M | 7,816,926 | 4.4% |
| Insmed IncCall | CALL | 457669907 | $16.8M | 250,000 | 4.0% |
| Morphic Hldg Inc | COM | 61775R105 | $16.6M | 486,306 | 3.9% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $14.7M | 625,087 | 3.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $13.9M | 374,910 | 3.3% |
| Intra-Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $13.2M | 192,345 | 3.1% |
| Poseida Therapeutics Inc(PSTXUSD) | COM | 73730P108 | $10.5M | 3,607,999 | 2.5% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $10.2M | 1,206,214 | 2.4% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $9.4M | 140,000 | 2.2% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $8.7M | 36,000 | 2.1% |
| Elutia Inc(ELUT) | CL A COM | 05479K106 | $8.0M | 1,603,580 | 1.9% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $7.8M | 172,492 | 1.8% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $7.6M | 1,075,812 | 1.8% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $7.6M | 370,000 | 1.8% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $7.6M | 184,662 | 1.8% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $6.7M | 1,442,841 | 1.6% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $6.6M | 42,000 | 1.6% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $6.6M | 560,883 | 1.6% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $6.1M | 282,248 | 1.4% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $6.0M | 455,800 | 1.4% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $5.9M | 546,863 | 1.4% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $5.6M | 1,768,770 | 1.3% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $5.1M | 500,000 | 1.2% |
| Mersana Therapeutics Inc | COM | 59045L106 | $5.0M | 2,500,585 | 1.2% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $5.0M | 5,500,000 | 1.2% |
| Tela BIO Inc(TELA) | COM | 872381108 | $4.7M | 1,000,000 | 1.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $4.6M | 101,187 | 1.1% |
| Biogen Inc(BIIB) | COM | 09062X103 | $4.5M | 19,365 | 1.1% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $4.4M | 304,633 | 1.0% |
| Geron Corp(GERN) | COM | 374163103 | $4.2M | 999,270 | 1.0% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $3.5M | 100,000 | 0.8% |
| Longboard Pharmaceuticals in | COM | 54300N103 | $3.3M | 122,849 | 0.8% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $2.8M | 67,296 | 0.7% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $2.8M | 70,516 | 0.7% |
| Biodesix Inc | COM | 09075X108 | $2.8M | 1,808,959 | 0.7% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $2.7M | 79,194 | 0.6% |
| Solid Biosciences Inc(SLDB) | COM NEW | 83422E204 | $2.7M | 472,995 | 0.6% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $2.6M | 260,009 | 0.6% |
| Cerus Corp(CERS) | COM | 157085101 | $2.6M | 1,465,744 | 0.6% |
| Compugen LTD(CGEN) | ORD | M25722105 | $2.5M | 1,501,113 | 0.6% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $2.5M | 844,235 | 0.6% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $2.5M | 1,062,062 | 0.6% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $2.5M | 109,892 | 0.6% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $2.5M | 263,841 | 0.6% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $2.5M | 495,471 | 0.6% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $2.5M | 398,436 | 0.6% |